All of SBH Sciences’ monoclonal antibodies are biologically active. They are produced in cells and are highly specific. This high level of specificity makes them valuable tools for research, diagnostics, and therapeutic applications in areas including cancer, autoimmune disorders, and infectious diseases.
At SBH Sciences, we are committed to providing high-quality research products to the market with precision. Our proprietary processes have achieved commercial production of 33 monoclonal antibodies, sold globally for 27 years.
Process development including serum-free media optimization, mid-scale production, and purification is available.
